These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 16394289)
1. Clinical relevance of Fas expression in oesophageal squamous cell carcinoma. Chan KW; Lee PY; Lam AK; Law S; Wong J; Srivastava G J Clin Pathol; 2006 Jan; 59(1):101-4. PubMed ID: 16394289 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of Fas and Fas ligand expressions in human esophageal cancer. Shibakita M; Tachibana M; Dhar DK; Kotoh T; Kinugasa S; Kubota H; Masunaga R; Nagasue N Clin Cancer Res; 1999 Sep; 5(9):2464-9. PubMed ID: 10499620 [TBL] [Abstract][Full Text] [Related]
3. Reduced axin protein expression is associated with a poor prognosis in patients with squamous cell carcinoma of esophagus. Li AF; Hsu PK; Tzao C; Wang YC; Hung IC; Huang MH; Hsu HS Ann Surg Oncol; 2009 Sep; 16(9):2486-93. PubMed ID: 19582507 [TBL] [Abstract][Full Text] [Related]
4. Expression of heat-shock protein Hsp60 correlated with the apoptotic index and patient prognosis in human oesophageal squamous cell carcinoma. Faried A; Sohda M; Nakajima M; Miyazaki T; Kato H; Kuwano H Eur J Cancer; 2004 Dec; 40(18):2804-11. PubMed ID: 15571964 [TBL] [Abstract][Full Text] [Related]
5. Fas and WAF1 expression in esophageal squamous cell carcinomas. Vlachos K; Siafakas N; Karameris A; Athanasas G; Theodoropoulos G; Parassi E; Peros G; Papadopoulos J; Hakim N Int Surg; 2006; 91(6):320-5. PubMed ID: 17256429 [TBL] [Abstract][Full Text] [Related]
6. mTOR in squamous cell carcinoma of the oesophagus: a potential target for molecular therapy? Boone J; Ten Kate FJ; Offerhaus GJ; van Diest PJ; Rinkes IH; van Hillegersberg R J Clin Pathol; 2008 Aug; 61(8):909-13. PubMed ID: 18474542 [TBL] [Abstract][Full Text] [Related]
7. Increased E2F-1 expression via tumour cell proliferation and decreased apoptosis are correlated with adverse prognosis in patients with squamous cell carcinoma of the oesophagus. Yamazaki K; Hasegawa M; Ohoka I; Hanami K; Asoh A; Nagao T; Sugano I; Ishida Y J Clin Pathol; 2005 Sep; 58(9):904-10. PubMed ID: 16126868 [TBL] [Abstract][Full Text] [Related]
8. CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma. Sano A; Kato H; Sakurai S; Sakai M; Tanaka N; Inose T; Saito K; Sohda M; Nakajima M; Nakajima T; Kuwano H Ann Surg Oncol; 2009 Feb; 16(2):506-14. PubMed ID: 19050962 [TBL] [Abstract][Full Text] [Related]
9. Spontaneous apoptosis in advanced esophageal carcinoma: its relation to Fas expression. Shibakita M; Tachibana M; Dhar DK; Ohno S; Kubota H; Yoshimura H; Kinugasa S; Masunaga R; Nagasue N Clin Cancer Res; 2000 Dec; 6(12):4755-9. PubMed ID: 11156230 [TBL] [Abstract][Full Text] [Related]
10. Prognostic role of PGE2 receptor EP2 in esophageal squamous cell carcinoma. Kuo KT; Wang HW; Chou TY; Hsu WH; Hsu HS; Lin CH; Wang LS Ann Surg Oncol; 2009 Feb; 16(2):352-60. PubMed ID: 19050969 [TBL] [Abstract][Full Text] [Related]
11. Meta-analysis: clinicopathological and prognostic significance of cyclooxygenase-2 expression on oesophageal squamous cell carcinoma. Li L; Zhao J; Wu Z; Wang G; Chen G Aliment Pharmacol Ther; 2009 Sep; 30(6):589-96. PubMed ID: 19549265 [TBL] [Abstract][Full Text] [Related]
12. Fas expression is associated with a better prognosis in laryngeal squamous cell carcinoma. Asensio C; Zapata A; García-Ahijado J; Gil B; Salvadores P; Schneider J Anticancer Res; 2007; 27(6B):4083-6. PubMed ID: 18225575 [TBL] [Abstract][Full Text] [Related]
13. Dickkopf-1 expression as a marker for predicting clinical outcome in esophageal squamous cell carcinoma. Makino T; Yamasaki M; Takemasa I; Takeno A; Nakamura Y; Miyata H; Takiguchi S; Fujiwara Y; Matsuura N; Mori M; Doki Y Ann Surg Oncol; 2009 Jul; 16(7):2058-64. PubMed ID: 19408050 [TBL] [Abstract][Full Text] [Related]
14. [Expression of fascin and cytokeratin 14 in esophageal squamous cell carcinoma]. Xue LY; Song YM; Tong T; Luo W; Dong LJ; Zou SM; Zheng S; Bi R; Zhan QM; Lü N Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2494-8. PubMed ID: 18067814 [TBL] [Abstract][Full Text] [Related]
15. Oesophageal basaloid squamous cell carcinoma: a unique clinicopathological entity with telomerase activity as a prognostic indicator. Lam KY; Law S; Luk JM; Wong J J Pathol; 2001 Nov; 195(4):435-42. PubMed ID: 11745675 [TBL] [Abstract][Full Text] [Related]
16. [Up-regulation of HOXA13 in esophageal squamous cell carcinoma of stage IIa and its effect on the prognosis]. Yan WP; Shen LY; Gu ZD; Chen KN Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jan; 12(1):20-3. PubMed ID: 19145497 [TBL] [Abstract][Full Text] [Related]
17. Expression of cytokeratin 7 predicts survival in stage I/IIA/IIB squamous cell carcinoma of the esophagus. Yamada A; Sasaki H; Aoyagi K; Sano M; Fujii S; Daiko H; Nishimura M; Yoshida T; Chiba T; Ochiai A Oncol Rep; 2008 Nov; 20(5):1021-7. PubMed ID: 18949396 [TBL] [Abstract][Full Text] [Related]
18. REG I expression predicts long-term survival among locally advanced thoracic squamous cell esophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by esophagectomy. Motoyama S; Sugiyama T; Ueno Y; Okamoto H; Takasawa S; Nanjo H; Watanabe H; Maruyama K; Okuyama M; Ogawa J Ann Surg Oncol; 2006 Dec; 13(12):1724-31. PubMed ID: 17009160 [TBL] [Abstract][Full Text] [Related]